Richard Riedel

K-ras Mutation Subtypes in NSCLC and Associated Co-occuring Mutations in Other Oncogenic Pathways

Matthias Scheffler, Michaela A. Ihle, Rebecca Hein et al. · Journal of Thoracic Oncology · 2018 · 247 citations · Full text

Impact of TP53 mutation status on systemic treatment outcome in ALK-rearranged non-small-cell lung cancer

Anna Kron, Christina Alidousty, Matthias Scheffler et al. · Annals of Oncology · 2018 · 207 citations · Full text

Combined VEGF and PD-L1 Blockade Displays Synergistic Treatment Effects in an Autochthonous Mouse Model of Small Cell Lung Cancer

Lydia Meder, Philipp Schuldt, Martin Thelen et al. · Cancer Research · 2018 · 165 citations · Full text

Safety and Efficacy of Crizotinib in Patients With Advanced or Metastatic ROS1-Rearranged Lung Cancer (EUCROSS): A European Phase II Clinical Trial

Sebastian Michels, Bartomeu Massutí, Hans‐Ulrich Schildhaus et al. · Journal of Thoracic Oncology · 2019 · 128 citations · Full text

Oncology, Cancer Management, Pathology +6

Structural Alterations of MET Trigger Response to MET Kinase Inhibition in Lung Adenocarcinoma Patients

Dennis Plenker, Miriam Bertrand, Adrianus J. de Langen et al. · Clinical Cancer Research · 2017 · 92 citations